B-acute leukemic lymphoblasts versus hematogones: the wolf in sheep's clothing/.
Kalff
Anna
A
Department of Diagnostic Haematology, Royal Melbourne Hospital, Parkville, Melbourne, Australia. akalff@hotmail.com
Juneja
Surender
S
D015703:Antigens, CD / Q000032:analysis; D018941:Antigens, CD19 / Q000032:analysis; D018952:Antigens, CD34 / Q000032:analysis; D001081:Apyrase / Q000032:analysis; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology*; D001854:Bone Marrow Cells / Q000166:cytology / Q000276:immunology*; D003593:Cytoplasm / Q000276:immunology; D005434:Flow Cytometry; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis; D017493:Leukocyte Common Antigens / Q000032:analysis; D014411:Neoplastic Stem Cells / Q000276:immunology* / Q000473:pathology; D015260:Neprilysin / Q000032:analysis; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology* / Q000473:pathology; D051918:Sialic Acid Binding Ig-like Lectin 2 / Q000032:analysis
D015703:Antigens, CD; D018941:Antigens, CD19; D018952:Antigens, CD34; D007075:Immunoglobulin M; D051918:Sialic Acid Binding Ig-like Lectin 2; D017493:Leukocyte Common Antigens; D015260:Neprilysin; D001081:Apyrase; C067869:CD39 antigen